News | Breast Imaging | December 16, 2024

With ASPIRE Cristalle AWS, organizations within the DoD network will be able to securely acquire and access patients’ mammography images. 


 Dec. 16, 2024 — FUJIFILM Healthcare Americas Corporation has announced that its ASPIRE Cristalle Acquisition Workflow System (AWS), the workstation that is used in conjunction with the company’s 3D mammography system, has been granted a Risk Management Framework (RMF) and Authority to Operate (ATO) on U.S. Department of Defense (DoD) networks. 

The three-year ATO was awarded to Fujifilm for its ASPIRE Cristalle AWS version 9.x. The ASPIRE Cristalle AWS controls the exposure unit to acquire and process mammographic images. With this user-friendly, secure workstation, the operator can acquire and view the patient’s image(s) in as few as five seconds. With ASPIRE Cristalle AWS, organizations within the DoD network will be able to securely acquire and access patients’ mammography images.  

The DoD’s RMF provides a process that integrates security and risk management activities into the system development life cycle. The risk-based approach to security control selection and specification considers effectiveness, efficiency, and constraints due to applicable laws, directives, executive orders, policies, standards, and regulations. 

“This prestigious designation from the U.S. Government attests to Fujifilm’s commitment to delivering advanced solutions in women’s health that meet the most rigorous security standards,” says Henry Izawa, president and chief executive officer, FUJIFILM Healthcare America Corporation. “We are honored to have earned the ATO for our ASPIRE Cristalle AWS—technology which will optimize the end user’s workflow and will ultimately benefit physicians and patients throughout the Military Health System.” 

Click here to learn more about Fujifilm’s ASPIRE Cristalle AWS.  


Related Content

News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Artificial Intelligence

June 26, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced it ...

Time June 26, 2024
arrow
News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
News | Breast Density

June 6, 2024 — Subsequent rounds of abbreviated breast MRI (AB-MR) screening in patients with dense breasts had lower ...

Time June 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Radiology Business

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
arrow
Subscribe Now